A pneumococcal capsular polysaccharide vaccine induces a repertoire shift with increased V(H)3 expression in peripheral B cells from human immunodeficiency virus (HIV)-uninfected but not HIV-infected persons

Journal of Infectious Diseases

Volumn 181, Issue 4, 2000, Pages 1313-1321

  Chang, Q ^a   Abadi, J ^a   Alpert, P ^a   Pirofski, Liise anne ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M; PNEUMOCOCCUS VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; MALE; PRIORITY JOURNAL; VACCINATION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; BACTERIAL VACCINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN M; IMMUNOGLOBULIN VARIABLE REGION; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0034022546     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315405     Document Type: Article

References (43)

1. 1. Pirofski L, Casadevall A. Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev 1998;11:1-26.
2. 2. Black S, Shinefield H, Ray P, et al. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth-Lederle) in 37,000 infants and children: results of the Northern California Kaiser Permanente Trial [abstract 18]. Programs and abstracts of Pneumococcal Vaccines for the World 1998 (Washington, DC), 1998.
3. 3. Ahman H, Kayhty H, Tamminen P, et al. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants. Pediatr Infect Dis J 1996;15:134-9.
4. 4. Ahmed F, Steinhoff MC, Rodriguez-Barradas MC, et al. Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J Infect Dis 1996;173:83-90.
5. 5. Rodriguez-Barradas MC, Tharapel RA, Groover JE, et al. Colonization by Streptococcus pneumoniae among human immunodeficiency virus infected adults: prevalence of antibiotic resistance, impact of immunization, and characterization by polymerase chain reaction with BOX primers of isolates from persistent S. pneumoniae carriers. J Infect Dis 1997;175:590-7.
6. 6. Molrine DC, George S, Tarbell NJ, et al. Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment for Hodgkin disease. Ann Intern Med 1995;123:828-34.
7. 7. Rubins JB, Puri ADG, Loch J, et al. Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults. J Infect Dis 1998;178:431-40.
8. 8. Lane CH, Masur H, Edgar LC, et al. Abnormalities of B cell activation and immunoregulation in patients with AIDS. N Engl J Med 1983;309:453-8.
9. 9. Wisnewski A, Cavacini L, Posner M. Human antibody variable region gene usage in HIV-1 infection. J Acquir Immun Defic Syndr Hum Retroviral 1996;11:31-8.
10. H3 gene products: natural ligands for HIV gp120. Science 1993;261:1588-91.
11. H3(D12 idiotope) B cells in vivo. J Acquir Immune Defic Syndr 1994;7:641-6.
12. H1 gene family expression in peripheral B cell IgM, IgD and IgG during HIV infection. Eur J Immunol 1995;25:1524-8.
13. H3 gene segment usage. J Infect Dis 1998;178:707-16.
14. 14. Zhong Z, Burns T, Chang Q, et al. Molecular and functional characteristics of a protective human monoclonal antibody to serotype 8 Streptococcus pneumoniae capsular polysaccharide. Infect Immun 1999;67:4119-27.
15. 15. Lucas AH, Granoff DM, Mandrell RE, et al. Oligoclonality of serum immunoglobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14, and 23F. Infect Immun 1997;65:5103-9.
16. 16. Kowal C, Weinstein A, Diamond B. Molecular mimicry between bacterial and self antigen in a patient with systemic lupus erythematosus. Eur J Immunol 1999;29:1901-11.
17. 17. Sun Y, Park MK, Kim J, et al. Repertoire of human antibodies against the polysaccharide capsule of Streptococcus pneumoniae serotype 6B. Infect Immun 1999;67:1172-9.
18. 18. Bessudo A, Rassenti L, Havlir D, et al. Aberrant and unstable expression of immunoglobulin genes in persons infected with human immunodeficiency virus. Blood 1998;92:1317-23.
19. H gene repertoire by an anchored PCR-Elisa. Ann NY Acad Sci 1995;764:463-73.
20. H gene repertoire is genetically controlled and unaltered by chronic autoimmune stimulation. J Clin Invest 1996;98:2794-800.
21. 21. Shaw DR, Kirkham P, Schroeder HW Jr, et al. Structure-function studies of human monoclonal antibodies to pneumococcus type 3 polysaccharide. Ann NY Acad Sci 1995;764:370-3.
22. 22. Feeney AJ, Atkinson MJ, Cowan MJ, et al. A defective VK A2 allele in Navajos which may play a role in increased susceptibility to Haemophilus influenzae type b disease. J Clin Invest 1996;97:2277-82.
23. 23. Butler JC, Breiman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993;270:1826-31.
24. 24. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453-60.
25. 25. Robbins JB, Schneerson R, Glode MP, et al. Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria. J Allergy Clin Immunol 1975;56:141-51.
26. 26. Tangye SG, Liu YJ, Aversa G, et al. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med 1998;188:1691-703.
27. 27. Peset Llopis MJ, Harms G, Hardonk MJ, et al. Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells. J Allergy Clin Immunol 1996;97:1015-24.
28. 28. Tierens A, Delabie J, Michiels L, et al. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutation and display clonal expansion. Blood 1999;93:226-34.
29. 29. Heilmann C. Human B and T lymphocyte responses to vaccination with pneumococcal polysaccharides. APMIS Suppl 1990;15:1-23.
30. 30. Storek J, King L, Ferrara S, et al. Abundance of restricted fetal B cell repertoire in marrow transplant recipients. Bone Marrow Transplant 1994; 14:783-90.
31. H3 rearrangements after allogenic bone marrow transplantation. Bone Marrow Transplant 1998;21:1223-30.
32. H clan and family identity predicts variable domain structure and may influence antigen binding. EMBO J 1992;11:603-9.
33. H region genes encoding IgE antibodies in splenic B lymphocytes of a patient with asthma. J Immunol 1999;154:5576-81.
34. 34. Snow RE, Chapman AJ, Holgate ST, et al. Immunogenetics of human IgE. Hum Antibodies Hybridomas 1996;7:157-66.
35. 35. Small CB, Kaufman A, Armenaka M, et al. Sinusitis and atopy in human immunodeficiency virus infection. J Infect Dis 1993;167:283-90.
36. H4 genes in AIDS-associated B-cell lymphoma. Blood 1996;88: 252-60.
37. 37. Weiss PJ, Wallace MR, Oldfield EC3, et al. Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine. J Infect Dis 1995;171:1217-22.
38. 38. Schucat A, Broome CV, Hightower A, et al. Use of surveillance in New Jersey to estimate the size of the immunosuppressed HIV-infected population. JAMA 1991;265:3275-9.
39. 39. Janoff EN, Breiman RF, Daley CL, et al. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992;117:314-24.
40. 40. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Study Group. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. N Engl J Med 1991;325:73-80.
41. 41. Watson DA, Musher DM, Jacobson JW, et al. A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery. Clin Infect Dis 1993;17:913-24.
42. 42. Morris L, Binley JM, Clas BA, et al. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med 1999;188:233-15.
43. H family in HIV-infected patients: modulation by triple combination therapy. AIDS Res Hum Retroviruses 1999;15: 315-6.